An injectable sulfonated reversible thermal gel for therapeutic angiogenesis to protect cardiac function after a myocardial infarction

dc.contributor.authorLee, David J.
dc.contributor.authorCavasin, Maria A.
dc.contributor.authorRocker, Adam J.
dc.contributor.authorSoranno, Danielle E.
dc.contributor.authorMeng, Xianzhong
dc.contributor.authorShandas, Robin
dc.contributor.authorPark, Daewon
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2022-07-29T14:08:47Z
dc.date.available2022-07-29T14:08:47Z
dc.date.issued2019-01-17
dc.description.abstractBackground: Cardiovascular disease and myocardial infarction are associated with high mortality and morbidity and a more effective treatment remains a major clinical need. The intramyocardial injection of biomaterials has been investigated as a potential treatment for heart failure by providing mechanical support to the myocardium and reducing stress on cardiomyocytes. Another treatment approach that has been explored is therapeutic angiogenesis that requires careful spatiotemporal control of angiogenic drug delivery. An injectable sulfonated reversible thermal gel composed of a polyurea conjugated with poly(N-isopropylacrylamide) and sulfonate groups has been developed for intramyocardial injection with angiogenic factors for the protection of cardiac function after a myocardial infarction. Results: The thermal gel allowed for the sustained, localized release of VEGF in vivo with intramyocardial injection after two weeks. A myocardial infarction reperfusion injury model was used to evaluate therapeutic benefits to cardiac function and vascularization. Echocardiography presented improved cardiac function, infarct size and ventricular wall thinning were reduced, and immunohistochemistry showed improved vascularization with thermal gel injections. The thermal gel alone showed cardioprotective and vascularization properties, and slightly improved further with the additional delivery of VEGF. An inflammatory response evaluation demonstrated the infiltration of macrophages due to the myocardial infarction was more significant compared to the foreign body inflammatory response to the thermal gel. Detecting DNA fragments of apoptotic cells also demonstrated potential anti-apoptotic effects of the thermal gel. Conclusion: The intramyocardial injection of the sulfonated reversible thermal gel has cardioprotective and vascularization properties for the treatment of myocardial infarction.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationLee DJ, Cavasin MA, Rocker AJ, et al. An injectable sulfonated reversible thermal gel for therapeutic angiogenesis to protect cardiac function after a myocardial infarction. J Biol Eng. 2019;13:6. Published 2019 Jan 17. doi:10.1186/s13036-019-0142-yen_US
dc.identifier.urihttps://hdl.handle.net/1805/29663
dc.language.isoen_USen_US
dc.publisherBMCen_US
dc.relation.isversionof10.1186/s13036-019-0142-yen_US
dc.relation.journalJournal of Biological Engineeringen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePMCen_US
dc.subjectReversible thermal gelen_US
dc.subjectIntramyocardial biomaterial injectionen_US
dc.subjectTherapeutic angiogenesisen_US
dc.subjectSulfonationen_US
dc.subjectHeparin-mimickingen_US
dc.subjectSpatiotemporal releaseen_US
dc.titleAn injectable sulfonated reversible thermal gel for therapeutic angiogenesis to protect cardiac function after a myocardial infarctionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
13036_2019_Article_142.pdf
Size:
4.23 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: